Microvascular Injury and Blood-brain Barrier Dysfunction as Novel Biomarkers and Targets for Treatment in Traumatic Brain Injury
CompletedOBSERVATIONAL
Enrollment
2
Participants
Timeline
Start Date
August 3, 2017
Primary Completion Date
August 3, 2019
Study Completion Date
August 3, 2021
Conditions
Traumatic Brain InjuryBlood Brain Barrier Defect
Trial Locations (1)
B3H 3A7
Halifax Infirmary, Halifax
All Listed Sponsors
lead
Nova Scotia Health Authority
OTHER
NCT03139682 - Microvascular Injury and Blood-brain Barrier Dysfunction as Novel Biomarkers and Targets for Treatment in Traumatic Brain Injury | Biotech Hunter | Biotech Hunter